Evidence map›Paper›PMID 38239633›Full record

ArticleFrontiers in oncology2023

Impact of smoking status on health-related quality of life (HRQoL) in cancer survivors.

José Ignacio Nolazco, Bernard A Rosner, Emily H Roebuck, Cristiane Decat Bergerot, Elke Rammant, Geetha S Iyer, Yuzhe Tang, Ra'ad Al-Faouri, Dejan K Filipas, Michael S Leapman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

José Ignacio NolazcoDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Bernard A RosnerChanning Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA, United States.
Emily H RoebuckDepartment of Urology, Carolinas Medical Center/Atrium Health, Charlotte, NC, United States.
Cristiane Decat BergerotCentro de Câncer de Brasília, Instituto Unity de Ensino e Pesquisa, Grupo Oncoclinicas, Brasília, DF, Brazil.
Elke RammantDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Geetha S IyerDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Yuzhe TangUrology Department, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Ra'ad Al-FaouriDepartment of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Dejan K FilipasDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Michael S LeapmanYale School of Medicine, Department of Urology, New Haven, CT, United States.
Matthew MossanenDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Steven Lee ChangDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Harvard University · USBrigham and Women's Hospital · USBeijing Tsinghua Chang Gung Hospital · CNCarolinas Medical Center · USGhent University · BEUniversity Medical Center Hamburg-Eppendorf · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Health-Related Quality of Life (HRQoL) often declines among cancer survivors due to many factors. Some cancer patients who smoke before the cancer diagnosis continue this harmful habit, potentially contributing to a more significant decline in their HRQoL. Therefore, this study investigates the association between smoking status and HRQoL in cancer survivors. Methods: We conducted a cross-sectional study utilizing self-reported cancer history from 39,578 participants of the Behavioral Risk Factor Surveillance System (BRFSS) database, leveraging 2016 and 2020 year questionaries. A multidimensional composite outcome was created to assess HRQoL, integrating four distinct dimensions - general health, mental health, physical health, and activity limitations. After accounting for the complex survey design, logistic regression models were used to analyze the association between smoking status and poor HRQoL, adjusting for demographic, socioeconomic, and health-related confounders. Results: Our study found that, after adjusting for potential confounders, current smokers exhibited a significantly poorer HRQoL than never smokers (OR 1.65, 95%CI 1.40-1.93). Furthermore, former smokers showed a poorer HRQoL than never smokers; however, this association was not as strong as current smokers (OR 1.22, 95%CI 1.09-1.38). Conclusion: Our findings highlight the adverse association of smoking with poor HRQoL in cancer survivors, underscoring the importance of healthcare professionals prioritizing smoking cessation and providing tailored interventions to support this goal.

Indexed as

behavioral risk factors surveillance system (BRFSS)cancer survivorshealth-related quality of lifesmokingtobacco

Identifiers

PMID38239633
PMCPMC10795065
OpenAlexW4390581413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.